ClinicalTrials.Veeva

Menu

Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome

US Department of Veterans Affairs (VA) logo

US Department of Veterans Affairs (VA)

Status

Completed

Conditions

Irritable Bowel Syndrome

Treatments

Procedure: Viceral Perception Testing

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT00100425
CADE-ARCD2

Details and patient eligibility

About

The purpose of this study is to provide new information and to determine which kinds of brief, tolerable, experimental pain are affected by the drugs being studied in patients with irritable bowel syndrome, a disease that causes chronic abdominal pain. The effects of dextromethorphan, naloxone, and fentanyl on experimental pain stimuli will be tested in these studies to better understand what causes irritable bowel syndrome.

Sex

All

Ages

18 to 72 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

  • Patients with irritable bowel syndrome and healthy pain-free individuals (as controls) will be studied.
  • No medical condition that would contraindicate use of dextromethorphan, fentanyl or naloxone.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems